Cortexyme Appoints Marwan Sabbagh, MD, to its Board of Directors
2022-03-21
Cortexyme, Inc., a clinical-stage biopharmaceutical company pioneering upstream therapeutic approaches to improve the lives of patients diagnosed with degenerative diseases, has announced the appointment of
